Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Am J Clin Oncol. 2018 Jul;41(7):708–715. doi: 10.1097/COC.0000000000000351

Figure 2. Proportion of non-adherent patients who went greater than 120 consecutive days without medication on-hand, considered to have discontinued adjuvant endocrine therapy, (n=1,790).

Figure 2

*By definition, patients were considered to have discontinued AET medication if they had greater than 120 days without medication on-hand and therefore patients could only be considered to have discontinued therapy up to the 8th month after initial prescription fill. Patients were considered to have discontinued AET medication the month that they last filled medication.